Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Injured in Crash on Colima Road


Pedestrian Hit by Hit and Run Driver in Rowland Heights Accident

Rowland Heights, CA (March 29, 2020) – A man was injured in a pedestrian crash in Rowland Heights. The accident occurred on the evening of March 29 on Colima Road.

A man in his 30s was crossing Colima Road, near Pepperdale Drive, when he was hit by a vehicle. The vehicle fled the accident scene. The victim, a man from Rowland Heights, was injured and taken to a local hospital. Police have no description of the driver or vehicle. 

#Rowland Heights

#91748


October 4, 2019

Motorcyclist Injured in Crash on Highway 4 Near San Marco Boulevard

Motorcycle, SUV Collide in Bay Point Accident Bay Point, CA (October 3, 2019) ...


October 10, 2019

1 Injured in Crash on Highway 198 Near Road 156

2 Vehicles Involved in Visalia Accident Visalia, CA (October 10, 2019) – One ...


April 29, 2020

Man Killed in Pedestrian Crash on B Street

Pickup Truck Hits Pedestrian in Fatal Hit and Run Accident in San Diego...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.